These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 21811052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S.
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
    Matthews JL, Dubovy SR, Goldberg RA, Flynn HW.
    Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
    [Abstract] [Full Text] [Related]

  • 6. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Moshfeghi AA, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA.
    Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
    [Abstract] [Full Text] [Related]

  • 7. Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Inman ZD, Anderson NG.
    Retina; 2011 Apr; 31(4):669-72. PubMed ID: 21178659
    [Abstract] [Full Text] [Related]

  • 8. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK.
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    El-Ashry MF, Dhillon B.
    Retina; 2009 May; 29(5):720-1; author reply 721-2. PubMed ID: 19430287
    [No Abstract] [Full Text] [Related]

  • 11. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.
    Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J, Klancnik J, Cooney M.
    Am J Ophthalmol; 2008 May; 145(5):879-82. PubMed ID: 18329624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).
    Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.
    Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198
    [Abstract] [Full Text] [Related]

  • 17. LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.
    Freiberg FJ, Brynskov T, Munk MR, Sørensen TL, Wolf S, Wirth MA, Becker M, Michels S.
    Retina; 2017 Dec; 37(12):2341-2346. PubMed ID: 28099318
    [Abstract] [Full Text] [Related]

  • 18. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.
    Casparis H, Wolfensberger TJ, Becker M, Eich G, Graf N, Ambresin A, Mantel I, Michels S.
    Retina; 2014 Jan; 34(1):12-7. PubMed ID: 23945639
    [Abstract] [Full Text] [Related]

  • 19. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
    Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S, Post-Injection Endophthalmitis (PIE) Study Group.
    Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
    [Abstract] [Full Text] [Related]

  • 20. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
    Gregori NZ, Flynn HW, Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi AA, Fortun JA, Kovach JL, Dubovy SR, Albini TA, Davis JL, Berrocal AM, Smiddy WE.
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):643-8. PubMed ID: 26114845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.